The latest announcement is out from Moleculin Biotech ( (MBRX) ).
Moleculin Biotech, Inc. is leveraging a new corporate presentation for its stakeholders, accessible via their website. This presentation, dated November 12, 2024, is intended for informational purposes and is not incorporated into any filings under the Securities Exchange Act or the Securities Act, which ensures transparency and clarity for investors.
See more data about MBRX stock on TipRanks’ Stock Analysis page.
